SERVICE

Online Inquiry

For Lab Research Use Only, Not for Human or Animal Therapeutic Use.

  • Verification code
    Click image to refresh the verification code.

Immune System Activation Study


Generally, gene therapy-based I-O products are designed to work in conjunction with the host immune system to increase native anti-tumor responses. The use of genetically engineered oncolytic viruses, cancer vaccines and adoptive cell transfer therapy enhances the anti-tumor ability of immune system. In addition, the administration of immune checkpoint inhibitors or immuno-modulatory cytokines is also able to reverse and switch on adaptive immunity. The activation events of immune system include the synthesis of cytokines, the clustering of cell surface receptors, T cell proliferation, the increased uptake of metabolites and ions, and changes in intracellular ATP levels, etc. As a world-renowned life science service provider, Creative Biolabs offers a range of immune system activation assays to support our clients’ gene therapy-based I-O drugs development.

Design elements of a multiplexed immune-modulating I-O drugs. Figure 1. Design elements of a multiplexed immune-modulating I-O drugs. (Twumasi, 2018)

Featured Immune System Activation Assays

Cytokine is an important consideration in gene therapy-based I-O drug development, specifically in host responses to infection, immune responses, inflammation, and cancer. We provide various types of cytokine response assays for our clients, including chemokines, interferons, and interleukins, etc.

T cell activation requires at least two signals such as the engagement of TCR by antigen/MHC complex and the subsequent engagement of co-stimulatory molecules. T cells stimulated by antigens divide in response to a series of activation events. GTOnco™ Platform has the ability to conduct multiple in vitro assays to assess the T cell activation and T cell proliferation.

Antigen-specific stimulation changes the trafficking properties of T cells and these activated and effector T cells are able to effectively and specifically home to other organs. We offer the best-fit in vitro T cell trafficking assays to visualize organ-specific homing of T cells.

As the orchestrators and effectors of the adaptive immune response, the function of T lymphocytes is directed by the specificity of their T cell receptors (TCRs). GTOnco™ platform provides high-quality in vitro assays to test the specificity of engineered T cells for interested antigens, such as CAR-T and TCR-T products.

The exogenous antigens are normally presented to CD8+ T cells via MHC-I presentation, which can occur and trigger an immune response. The identification of MHC-I presented peptides is important for the gene therapy-based I-O drug development, such as cancer vaccine. By using MHC-associated peptide proteomics assays (MPPAs), GTOnco™ platform is able to measure relative quantification and affinity of peptides isolated from MHC-I molecules.

Macrophages exert multiple functions including modulating the adaptive immune response and responding to pathogens. Different populations of macrophages can be developed in response to different stimuli. GTOnco™ platform provides in vitro macrophage polarization assays to induce different macrophage subsets.

Immature dendritic cells (DCs) with strong migration ability are activated by the hapten-protein complex and undergo maturation and differentiate from antigen-capture and processing cells into potent immunostimulatory DCs to present antigen effectively to effector T-cells. We provide custom in vitro dendritic cell migration assay (DCMA) to evaluate the DC migration.

Creative Biolabs has established a perfect GTOnco™ platform to facilitate a wide range of projects for numerous clients. We are committed to offering the most efficient assay to support your gene therapy-based I-O drugs development. Please don’t hesitate to contact us and let us know your specific requirement.

Reference

  1. Twumasi-Boateng, K.; et al. (2018). Oncolytic viruses as engineering platforms for combination immunotherapy. Nature Reviews Cancer, 18(7), pp.419-432.

For Lab Research Use Only, Not for Human or Animal Therapeutic Use.

Other GTOnco™ I-O Assays for In Vitro Study:

Interested in our expertise?

Contact us for more information

Get free consultations

USA

  • Tel:
  • Email:

Europe

Easy access to products and services you need from our library via powerful searching tools

Enter your email here to subscribe.

Submit

Follow us on

For Lab Research Use Only, Not for Human or Animal Therapeutic Use.

Copyright © 2021 Creative Biolabs. All Rights Reserved.